Wilmer Cutler Pickering Hale and Dorr advised Karyopharm Therapeutics Inc. on the transactions. Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies,...
You must be a Standard 1 Year member to access this content.
Haynes and Boone is advising BiomX Inc. on the transaction, Cooley is advising Adaptive Phage Therapeutics and Wilmer Cutler Pickering Hale and Dorr is advising the...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised Verde Bioresins, Inc., while Cleary Gottlieb Steen?& Hamilton advised TLGY Acquisition Corporation in the transaction. Verde Bioresins, Inc. announced it...
You must be a Standard 1 Year member to access this content.
Pérez Correa González advised Swvl Holding Corp. on the deal. WilmerHale and Ritch Mueller advised Urbvan Mobility Spa. Nasdaq-listed transportation startup Swvl Holdings Corp. executed the...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised Jackson Acquisition Company on the deal. Jackson Acquisition Company, a special purpose acquisition company led by chairman of the...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Crescera Capital Acquisition Corp. on the deal while Wilmer Cutler Pickering Hale and Dorr represented the underwriter. Crescera Capital Acquisition Corp. executed its...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised Cue Health Inc. on the deal. Cue Health Inc., a health technology company, announced the closing of its $235...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised Amplitude Healthcare Corporation on the deal while Paul Hastings represented Jasper Therapeutics. Amplitude Healthcare Corporation (Nasdaq: AMHC), a special...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr LLP advised the underwriters on the deal. NeuBase Therapeutics, Inc. (Nasdaq: NBSE), (“NeuBase”), a biotechnology company accelerating the genetic revolution...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised Altimeter Capital Management, LP on the deal. Skadden advised Grab Holdings. Grab Holdings Inc., Southeast Asia’s leading superapp, announced...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised Ameresco, Inc. on the deal. Ameresco, Inc., a leading clean technology integrator specializing in energy efficiency and renewable energy,...
You must be a Standard 1 Year member to access this content.
